Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease	Alzheimer disease, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Recruiting	Phase 1 / Phase 2	2026-09-23		NCT07651319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The Methodist Hospital Research Institute	124

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Houston Methodist Research Institute	Houston	United States	32

Clinical trials